2-Bromo-6β,9-Difluoro-11β,17,21-Trihydroxypregna-1,4-diene-3,20-dione 17,21-di(acetate)

CAS: 57781-14-3

Ref. 3D-FB101932

Produktinformation

• Name: 2-Bromo-6β,9-Difluoro-11β,17,21-Trihydroxypregna-1,4-diene-3,20-dione 17,21-di(acetate)
• Synonyme: (6Beta,11Beta)-2-Bromo-6,9-Difluoro-11-Hydroxy-3,20-Dioxopregna-1,4-Diene-17,21-Diyl Diacetate, (6β,11β)-17,21-Bis(acetyloxy)-2-bromo-6,9-difluoro-11-hydroxypregna-1,4-diene-3,20-dione, 17,21-Bis(acetyloxy)-2-bromo-6-beta,9-difluoro-11-beta-hydroxypregna-1,4-dien-3,20-dione, 17,21-Bis(acetyloxy)-2-bromo-6beta,9-difluoro-11beta-hydroxypregna-1,4-diene-3,20-dione, 2-Bromo-6beta,9-difluoro-11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione 17,21-di(acetate), 2-Bromo-6beta,9-difluoro-11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione 17,21-diacetate, Ccris 2685, Haloart, Halopredone 17,21-diacetate, Halopredone acetate [USAN:JAN], Halopredone diacetate, Pregna-1,4-diene-3,20-dione, 17,21-bis(acetyloxy)-2-bromo-6,9-difluoro-11-hydroxy-, (6beta,11beta)-, Pregna-1,4-diene-3,20-dione, 17,21-bis(acetyloxy)-2-bromo-6,9-difluoro-11-hydroxy-, (6β,11β)-, Ths-201, Topicon

Beschreibung

2-Bromo-6beta,9-Difluoro-11beta,17,21-Trihydroxypregna-1,4-diene-3,20-dione 17,21-di(acetate) is a model system for the study of choroidal neovascularization. It is a biocompatible polymer that has been shown to have antiinflammatory activity in vitro and in vivo studies. 2BDPMPDA is cytotoxic to cells at high concentrations due to its hydroxyl group. It shows inhibitory properties towards inflammation and infectious diseases. 2BDPMPDA also has receptor activity with fatty acid receptors.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 559.39 g/mol
• Formel: C₂₅H₂₉BrF₂O₇
• Reinheit: Min. 95%